OncoSil Medical

OncoSil Medical

Australia - Macquarie Park
Biotechnology
WebsiteLinkedInCareers Page

Focus: Beta radiation device

OncoSil Medical is a life sciences company focused on Beta radiation device.

Oncology
Funding Stage
PUBLIC
Employees
501-1000
Total Funding
$270M
Open Jobs
0

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT03003078A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane
N/A
N/A
Clinical Trials (1)
NCT03076216A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.
N/A
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
Pancreatic Neoplasm
N/A
Clinical Trials (1)
NCT04493632OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
N/A
N/A
Clinical Trials (1)
NCT06399172OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
N/A
FOLFIRINOX chemotherapy
Locally Advanced Pancreatic Cancer
Phase 2
Clinical Trials (1)
NCT05466799FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2021
Portfolio: 5 clinical trials